Advertisement
Screener

PMV PHARMACEUTICALS, INC. (PMVP) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

PMV PHARMACEUTICALS, INC. Cash Flow Breakdown

Cash flow breakdown shows where PMV PHARMACEUTICALS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $73.58M went out.
  • Fiscal year ended 2025-12-31: from investing, $70.17M came in.
  • Fiscal year ended 2025-12-31: from financing, $505.00K came in.
  • Fiscal year ended 2025-12-31: change in cash, $2.89M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$73.58M$70.17M$505.00K*-$2.89M
2024-12-31-$51.28M$53.35M$2.35M
2023-12-31-$55.66M-$50.55M$35.12M-$70.59M
2022-12-31-$63.76M-$1.37M$958.00K-$64.17M
2021-12-31-$46.57M-$143.58M$2.02M-$188.13M
2020-12-31-$32.74M$27.91M$223.18M$69.80M*$288.14M
2019-12-31-$22.07M$3.23M$100.00K$61.70M*$42.97M
2018-12-31-$15.18M$21.69M$6.51M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$14.58M*-$12.23M*
2026-03-31-$19.68M$20.82M$0.00$1.15M
2025-12-31-$17.19M*$18.44M*
2025-09-30-$19.82M*$12.03M*
2025-06-30-$18.30M*$10.99M*
2025-03-31-$18.27M$28.71M$10.00K$10.46M
2024-12-31-$16.66M*$7.74M*
2024-09-30-$16.84M*$17.12M*
2024-06-30-$1.60M*$2.32M*
2024-03-31-$16.18M$26.17M$0.00$9.95M
2023-12-31-$12.09M*-$2.59M*$0.00*
2023-09-30-$15.66M*-$33.64M*$33.09M*
2023-06-30-$12.90M*-$63.96M*$2.13M*
2023-03-31-$15.01M$49.65M$34.65M
2022-12-31-$15.32M*$23.22M*$548.00K*
2022-09-30-$16.76M*$29.51M*
2022-06-30-$13.68M*-$15.28M*
2022-03-31-$18.00M-$38.83M$128.00K-$56.70M
2021-12-31-$12.03M*$7.56M*$295.00K*
2021-09-30-$12.40M*-$693.00K*$309.00K*
2021-06-30-$9.24M*-$10.55M*$1.26M*
2021-03-31-$12.90M-$139.90M$162.00K-$152.64M
2020-12-31-$10.31M*-$57.00K*-$1.36M*
2020-09-30-$7.39M*$8.04M*$294.45M*
2020-06-30-$6.90M*$26.32M*
2020-03-31-$8.14M-$6.38M-$14.52M
2019-12-31-$5.13M*-$18.55M*$0.00*$61.70M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
Lunai Bioworks Inc. (LNAI)United States$0.072B-0.11
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Cingulate Inc. (CING)United States$0.073B-2.64
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
OS Therapies Inc (OSTX)United States$0.076B-2.17
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39